(Q38028610)

27 August 2017

title

Acute treatment of migraines (English)

1 reference

27 August 2017

1 reference

2

Stewart J Tepper

1 reference

27 August 2017

Arnaldo N Da Silva

1

1 reference

27 August 2017

publication date

1 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

26

1 reference

27 August 2017

issue

10

1 reference

27 August 2017

page(s)

823-839

1 reference

The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF).

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Cost of disorders of the brain in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Diencephalic and brainstem mechanisms in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Advances in the basic and clinical science of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Neurobiology of migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Effect of cortical spreading depression on basal and evoked traffic in the trigeminovascular sensory system.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Potential of the Migraine Disability Assessment (MIDAS) Questionnaire as a public health initiative and in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

A six-item short-form survey for measuring headache impact: the HIT-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: The Disability in Strategies for Care (DISC) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Neurogenically Mediated Plasma Extravasation in Dura Mater: Effect of Ergot Alkaloids: A Possible Mechanism of Action in Vascular Headache

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Rescue therapy for acute migraine, part 1: triptans, dihydroergotamine, and magnesium

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

DHE repression of ATP-mediated sensitization of trigeminal ganglion neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Intravenous dihydroergotamine for inpatient management of refractory primary headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Repetitive intravenous dihydroergotamine as therapy for intractable migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

A comparative trial of three agents in the treatment of acute migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Current emergency treatment of severe migraine headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Working Panel of the Headache and Facial Pain Section of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Safety and pharmacokinetics of dihydroergotamine mesylate administered via a Novel (Tempo) inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

5-HT1-like receptor agonists and the pathophysiology of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

The triptan formulations : how to match patients and products

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Sumatriptan and naproxen sodium for the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Intravenous chlorpromazine versus intramuscular sumatriptan for acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Rizatriptan RPD for severe migraine in the emergency department—a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

A clinical trial of trimethobenzamide/diphenhydramine versus sumatriptan for acute migraines

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Sumatriptan for the treatment of undifferentiated primary headaches in the ED.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Efficacy of low-dose ibuprofen in acute migraine treatment: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Efficacy and tolerability of diclofenac potassium sachets in migraine: a randomized, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: Results from the International Migraine Pain Assessment Clinical Trial (IMPACT)

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Association between a 19 bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

A prospective study of i.v. magnesium and i.v. prochlorperazine in the treatment of headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Paracetamol (acetaminophen) versus acetylsalicylic acid in migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

SUMATRIPTAN: a receptor-targeted treatment for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Randomized trial of IV dexamethasone for acute migraine in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Randomized controlled trial of intravenous dexamethasone to prevent relapse in acute migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Steroids for migraine headaches: a randomized double-blind, two-armed, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Excessive acute migraine medication use and migraine progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635440-000000000-00000

Abortive headache therapy in the office with intravenous dihydroergotamine plus prochlorperazine

21 January 2018

1 reference

12 December 2020

Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: A randomized trial

1 reference

12 December 2020

Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors

1 reference

12 December 2020

An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score

1 reference

12 December 2020

Clinical susceptibility to migraine with aura is modified by dopamine D 2 receptor (DRD2) Nco I alleles

1 reference

12 December 2020

Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials

1 reference

12 December 2020

Lost productive work time costs from health conditions in the United States: results from the American Productivity Audit

1 reference

12 December 2020

Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache

1 reference

12 December 2020

Basic mechanisms in vascular headache

1 reference

12 December 2020

EFNS guideline on the drug treatment of migraine - report of an EFNS task force

1 reference

12 December 2020

Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches

1 reference

12 December 2020

Pathophysiology of migraine--new insights.

1 reference

12 December 2020

Migraine in pregnancy

1 reference

12 December 2020

The pharmacology of the novel 5-HT1-like receptor agonist, GR43175.

1 reference

12 December 2020

Dihydroergotamine: pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs

1 reference

12 December 2020

Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache

1 reference

12 December 2020

Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults

1 reference

12 December 2020

Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers

1 reference

12 December 2020

A controlled study of dihydroergotamine in the treatment of acute migraine headache

1 reference

12 December 2020

Use of dopamine antagonists in treatment of migraine

1 reference

12 December 2020

Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double-blind trial

1 reference

12 December 2020

Oral sumatriptan for acute migraine

1 reference

12 December 2020

10.2165/11635440-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1027212082

0 references

1 reference